CBD for anxiety and stress: what the studies really show

26/09/2026
A hand holding a 10 ml bottle of Formula Swiss CBD oil in olive oil

Research on CBD for anxiety is promising and still developing. In small placebo-controlled trials, a single 300–600 mg dose taken by mouth lowered anxiety during a public-speaking test, and four weeks of CBD reduced social anxiety scores in 18- and 19-year-olds. These were research doses, not product advice. If anxiety affects your daily life, talk to a doctor.

Key facts

Best-studied situation
Public-speaking tests. Single doses of CBD lowered anxiety in people with social anxiety disorder and in healthy volunteers (Bergamaschi 2011; Zuardi 2017).
Longer use
A 4-week placebo-controlled trial and open-label studies of 4–12 weeks reported lower anxiety or burnout scores.
Doses in studies
300–600 mg as a single dose, or 25–800 mg a day over several weeks, taken by mouth in research settings.
More is not better
In two studies that compared doses, 300 mg lowered anxiety while lower and higher doses did not.
Safety
Generally well tolerated, according to the WHO. CBD can cause drowsiness and can interact with some medicines, including citalopram and clobazam.
Our products
Cosmetics for use on the skin. They are not intended to treat anxiety or any other condition.

Can CBD help with anxiety?

The research so far is encouraging. Since the 1990s, researchers have tested CBD in people facing a stressful task, in people diagnosed with social anxiety disorder and, more recently, over several weeks of daily use. Most of these studies found lower anxiety with CBD than with placebo or than at the start of the study. A review from New York University concluded that the human evidence supports a calming role for CBD, but that most studies tested a single dose and few involved people with an anxiety disorder (Blessing 2015).

That is where the field still stands. The trials are small, many come from one pioneering research group at the University of São Paulo in Ribeirão Preto, and larger placebo-controlled trials over longer periods are still needed. CBD is not an approved treatment for anxiety in Europe or the UK.

What did the key human studies find?

The table lists the main human studies, with their design and size. "Double-blind" means neither the participants nor the researchers knew who received CBD. All studies gave CBD by mouth.

Human studies of CBD for anxiety and stress (reviewed September 2026)
Study Who and how What was found
Zuardi 1993 40 healthy volunteers, double-blind, single 300 mg dose or placebo before a simulated speech Less anxiety after the speech
Crippa 2011 10 people with social anxiety disorder, double-blind crossover, single 400 mg dose Less self-rated anxiety; changes in emotion-related brain areas on a scan
Bergamaschi 2011 24 people with social anxiety disorder (12 CBD, 12 placebo) and 12 healthy controls, double-blind, single 600 mg dose before a simulated speech Less anxiety, discomfort and speech-related impairment; responses close to the healthy group
Zuardi 2017 60 healthy adults, double-blind, single 100, 300 or 900 mg dose or placebo before a real speech Less anxiety after the speech at 300 mg
Linares 2019 57 healthy men, double-blind, single 150, 300 or 600 mg dose or placebo Less anxiety during the speech at 300 mg
Masataka 2019 37 people aged 18–19 with social anxiety disorder, double-blind, 300 mg a day (17) or placebo (20) for 4 weeks Lower scores on two social anxiety scales
Shannon 2019 72 adults at a psychiatric clinic, chart review without a control group, mostly 25 mg a day alongside usual care Anxiety scores fell in the first month in 57 of 72 (79%) and stayed lower
Crippa 2021 120 frontline health workers, randomised, open-label, 300 mg a day plus standard care or standard care alone for 4 weeks Less emotional exhaustion (burnout) from day 14
Berger 2022 31 people aged 12–25 whose anxiety had not improved with therapy or antidepressants, open-label, up to 800 mg a day added for 12 weeks Anxiety severity down 42.6%
Kwee 2022 80 people with social anxiety or panic disorder, double-blind, 300 mg or placebo before each of 8 exposure-therapy sessions No added benefit over placebo
Bloomfield 2022 24 healthy adults, double-blind crossover, single 600 mg dose No change in lab-induced anxiety

Public-speaking studies

Speaking in front of others is one of the most reliable ways to make people anxious in a controlled setting, which is why so many CBD studies use it. The best-known example is the 2011 trial by Bergamaschi and colleagues. Twenty-four people with social anxiety disorder, none of whom had been treated before, received either 600 mg of CBD or a placebo about 90 minutes before a simulated public-speaking test. The placebo group became clearly more anxious and uncomfortable than a comparison group of 12 healthy volunteers. In the CBD group, anxiety, discomfort and negative thoughts about their own performance stayed much closer to the healthy group (Bergamaschi 2011).

Earlier studies from the same group had found less anxiety after 300 mg in healthy volunteers (Zuardi 1993) and after 400 mg in 10 people with social anxiety disorder, along with changes in the activity of brain areas involved in emotion (Crippa 2011).

Several weeks of use

In Japan, 37 young people aged 18 and 19 with social anxiety disorder took either an oil containing 300 mg of CBD or a placebo every day for four weeks. Both social anxiety scales used in the study showed a significant fall in the CBD group (Masataka 2019).

In Australia, 31 young people whose anxiety had not improved with talking therapy or antidepressants added CBD, up to 800 mg a day, for 12 weeks. Their anxiety severity fell by 42.6% on average, and mood and daily functioning also improved. There was no placebo group, so the authors call for randomised trials (Berger 2022).

At a psychiatric clinic in Colorado, doctors added CBD, mostly 25 mg a day in capsules, to usual care. In the chart review of 72 adults, anxiety scores fell within the first month in 79% of patients and stayed lower. This was a review of patient records without a control group, so it can suggest but not prove an effect (Shannon 2019). The same paper looked at sleep, which we cover in our guide to CBD oil and sleep.

Not every trial found an effect

As in any young field, results vary. In a Dutch trial, adding 300 mg of CBD to eight sessions of exposure therapy brought no extra benefit compared with placebo (Kwee 2022). In a UK study, a single 600 mg dose did not change anxiety induced in the lab in 24 healthy volunteers (Bloomfield 2022). Differences in dose, timing and the people studied may explain part of this, which is why larger trials are the next step.

Is there an ideal amount of CBD for anxiety?

Two studies from the São Paulo group tested several single doses against placebo before a public-speaking task. In both, the middle dose of 300 mg lowered anxiety, while the lower and higher doses did not differ from placebo. Researchers call this an inverted-U curve: the effect rises and then falls again as the dose goes up (Zuardi 2017; Linares 2019).

Single doses tested in two public-speaking studies and the result compared with placebo

Bar length shows the dose. Doses were taken by mouth in a research setting. Source: Zuardi et al., 2017; Linares et al., 2019.

Other studies found an effect at 400 and 600 mg, so 300 mg is not a fixed rule. What these studies do show is that a higher amount does not automatically mean a stronger effect.

Is everyday stress the same as an anxiety disorder?

No. The NHS points out that most people feel anxious or stressed sometimes, and that stress can even be helpful or motivating. An anxiety disorder is more likely when you feel anxious most of the time and it affects your everyday life (NHS, generalised anxiety disorder; NHS, stress).

Anxiety disorders are common. The World Health Organization estimates that 470 million people had one in 2023, which makes them the world's most common mental health condition. The WHO also stresses that highly effective treatments exist, yet only about 1 in 4 people with an anxiety disorder receive treatment (WHO).

For stress, the closest evidence comes from two kinds of study:

  • Short-term stress in the lab. The public-speaking studies above were run mainly in healthy volunteers, so they say most about a stressful moment rather than a disorder.
  • Work stress and burnout. In a Brazilian trial with 120 frontline health workers during the COVID-19 pandemic, those who took 300 mg of CBD a day for four weeks alongside standard care reported less emotional exhaustion than those who received standard care alone. Five people in the CBD group had serious side effects: four had raised liver enzymes and one had a severe skin reaction. Two stopped CBD, and both recovered fully (Crippa 2021).

The WHO's self-care advice for anxiety applies to stress too: regular exercise, regular sleep and meals, less alcohol, and relaxation or mindfulness techniques (WHO). CBD research sits alongside these habits and alongside professional care, not in place of them.

How do study doses compare with CBD cosmetics?

The anxiety trials gave CBD by mouth, in capsules or oil, at 300–600 mg as a single dose or 25–800 mg a day over several weeks. Researchers chose these amounts to measure an effect under study conditions, and participants were monitored. The doses are not recommendations for anyone to copy.

Our human CBD oils and creams are cosmetics, notified for use on the skin (CPNP in the EU, SCPN in the UK). Amounts applied to the skin cannot be compared with doses swallowed in a trial, so we do not translate study doses into drops. For how strengths and drops work on our labels, see our CBD oil dosage guide.

Is CBD safe with antidepressants and anti-anxiety medicines?

CBD is generally well tolerated with a good safety profile, and in people it shows no signs of abuse or dependence potential, according to the World Health Organization's expert committee (WHO ECDD 2018). The WHO adds that reported side effects may come from interactions with medicines people already take. That matters for anxiety, because many people with anxiety take medicine for it.

Taking medicine for anxiety, depression or sleep?

  • Antidepressants (SSRIs). In a 2026 study by the US Food and Drug Administration, healthy adults took CBD (2.5 mg per kg twice a day) for 12 days, and their exposure to citalopram rose by 43% (Salcedo 2026).
  • Benzodiazepines. With CBD, the active breakdown product of clobazam, a benzodiazepine, rose 3- to 4-fold. CBD can cause drowsiness, and other sedating medicines and alcohol can add to it (Epidyolex product information, EMA).
  • Don't stop or change a prescribed medicine without your doctor, and tell your doctor or pharmacist about every CBD product you use, including products for the skin.

Our guide to CBD and medication interactions covers other antidepressants, sleeping pills and more medicine groups.

In the 12-week Australian study, reported side effects included tiredness, low mood and hot flushes or chills, with none serious (Berger 2022), and two people in the Colorado case series stopped in the first week because of tiredness (Shannon 2019). For a full overview, including who should avoid CBD, see CBD side effects.

When should you see a doctor about anxiety or stress?

See a doctor if:

  • you feel anxious or worried most of the time, and it affects your work, relationships or daily life;
  • you are struggling to cope with stress, or the things you are trying yourself are not helping;
  • you have sudden panic attacks or overwhelming fears;
  • you have been diagnosed with an anxiety disorder and your treatment is not helping;
  • you take any regular medicine, are pregnant or breastfeeding, or are under 18, and are thinking about using CBD.

The first points follow NHS advice on anxiety and stress. Talking therapies based on cognitive behavioural therapy have the most evidence for anxiety disorders, and antidepressants such as SSRIs can also help adults, according to the WHO. In many countries you can ask your doctor for a referral, and in some you can refer yourself.

If you are in crisis

If you have thoughts of harming yourself, or you feel you cannot keep yourself safe, call your local emergency number or a crisis helpline now, or go to the nearest emergency department. You don't have to wait for an appointment, and you don't have to cope alone.

Why doesn't Formula Swiss promise results for anxiety?

Because the evidence comes from oral CBD at research doses, and because our human oils and creams are cosmetics for use on the skin, we make no claims that they relieve anxiety or stress. We would rather give you the studies as they are, and let your doctor help with the medical side.

Gas chromatograph with an autosampler tray of sample vials in Formula Swiss's lab
What we can vouch for is content: this equipment measures the cannabinoids in every batch.

What we can speak for is what is in the bottle: every production batch is tested, and we publish the certificates of analysis.

Frequently asked questions

Does CBD help with anxiety?

Research is promising and still developing. In small placebo-controlled trials, a single 300–600 mg dose taken by mouth lowered anxiety during a public-speaking test, and in a trial of 37 young adults, four weeks of 300 mg a day reduced social anxiety scores. Larger and longer trials are still needed.

Does CBD help with stress?

Most stress research uses public-speaking tests in healthy volunteers, where a single 300 mg dose lowered anxiety. In a trial of 120 health workers, 300 mg a day for four weeks alongside standard care reduced emotional exhaustion. Both studies gave CBD by mouth in a research setting.

How much CBD was used in anxiety studies?

Single doses of 300–600 mg, or 25–800 mg a day over 4–12 weeks, all taken by mouth. In two studies that compared doses, 300 mg worked better than lower or higher doses. These are research amounts, not product directions; our oils are cosmetics for use on the skin.

Can I take CBD with antidepressants?

Ask your doctor or pharmacist first. In a 2026 study, CBD raised exposure to the SSRI citalopram by 43% in healthy adults. Other antidepressants may be affected differently. Never stop or change a prescribed medicine on your own.

Can I take CBD with benzodiazepines?

Only with your doctor's approval. CBD raised the active breakdown product of the benzodiazepine clobazam 3- to 4-fold, and CBD can add to the drowsiness caused by sedating medicines and alcohol, according to the Epidyolex product information.

Is CBD addictive?

No signs of this have been found. The World Health Organization's expert committee concluded in 2018 that in humans CBD exhibits no effects indicative of any abuse or dependence potential, and that it is generally well tolerated.

Can CBD make anxiety worse?

The trials in this article did not report more anxiety with CBD; in two studies, the highest doses simply had no effect. Tiredness and low mood were among the side effects reported in one 12-week study. If you feel worse, stop and talk to your doctor.

Can CBD replace therapy or anxiety medication?

No. Talking therapies and medicines such as SSRIs are established treatments for anxiety disorders. Most CBD studies tested it alongside usual care, not instead of it. Don't stop or change any treatment without your doctor.

This article is general information and does not replace advice from your doctor or pharmacist. CBD products are not medicines and are not intended to diagnose, treat or prevent any disease. If you are in crisis, call your local emergency number or a crisis helpline.

Last reviewed:

Sources

  1. Bergamaschi MM et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology 2011;36(6):1219–26. PMID 21307846
  2. Zuardi AW et al. Effects of ipsapirone and cannabidiol on human experimental anxiety. J Psychopharmacol 1993;7(1 Suppl):82–8. PMID 22290374
  3. Crippa JA et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol 2011;25(1):121–30. PMID 20829306
  4. Zuardi AW et al. Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life. Front Pharmacol 2017;8:259. PMID 28553229
  5. Linares IM et al. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Braz J Psychiatry 2019;41(1):9–14. PMID 30328956
  6. Masataka N. Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders. Front Psychol 2019;10:2466. PMID 31787910
  7. Shannon S et al. Cannabidiol in anxiety and sleep: a large case series. Perm J 2019;23:18-041. PMID 30624194
  8. Crippa JAS et al. Efficacy and safety of cannabidiol plus standard care vs standard care alone for the treatment of emotional exhaustion and burnout among frontline health care workers during the COVID-19 pandemic: a randomized clinical trial. JAMA Netw Open 2021;4(8):e2120603. PMID 34387679
  9. Berger M et al. Cannabidiol for treatment-resistant anxiety disorders in young people: an open-label trial. J Clin Psychiatry 2022;83(5). PMID 35921510
  10. Kwee CM et al. Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: a randomised controlled trial. Eur Neuropsychopharmacol 2022;59:58–67. PMID 35561538
  11. Bloomfield MAP et al. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study. Psychopharmacology (Berl) 2022;239(5):1539–1549. PMID 35445839
  12. Blessing EM et al. Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics 2015;12(4):825–36. PMID 26341731
  13. Salcedo P et al. Clinical study to evaluate drug interactions of cannabidiol with citalopram and morphine in healthy adults. Clin Pharmacol Ther 2026;119(4):1095–1104. PMID 41622700
  14. European Medicines Agency. Epidyolex (cannabidiol): summary of product characteristics, sections 4.4 and 4.5.
  15. WHO Expert Committee on Drug Dependence. Cannabidiol (CBD): critical review report. 2018.
  16. World Health Organization. Anxiety disorders. Fact sheet, 15 September 2026.
  17. NHS. Generalised anxiety disorder in adults.
  18. NHS. Stress.
Späť na blog

Napísať komentár

Komentáre musia byť pred zverejnením schválené.

Robin Roy Krigslund-Hansen

Robin Roy Krigslund-Hansen

O autorovi

Robin Roy Krigslund-Hansen je zakladateľ a generálny riaditeľ spoločnosti Formula Swiss a zodpovedá za zloženie produktov. Od založenia spoločnosti v roku 2013 píše o konope, CBD a konopnom priemysle. Jeho pohľad vychádza z budovania spoločnosti Formula Swiss, rozhovorov s výskumníkmi a podpory výskumu CBD.

Viac o autorovi: Robin Roy Krigslund-Hansen

Súvisiace produkty